Literature DB >> 27756041

In-hospital worsening heart failure in patients admitted for acute heart failure.

Valentina Carubelli1, Gad Cotter2, Beth Davison2, Jemal Gishe3, Stefanie Senger2, Ivano Bonadei4, Elio Gorga4, Valentina Lazzarini4, Carlo Lombardi4, Marco Metra4.   

Abstract

BACKGROUND: In-hospital worsening heart failure (WHF) is predictive of worse post-discharge outcomes and has been recently used as an endpoint in clinical trials in acute heart failure (AHF).
METHODS: We described the clinical and prognostic significance of WHF in consecutive patients hospitalized for AHF at our institute. WHF was defined as worsening signs and symptoms of HF requiring treatment intensification. We compared WHF events by day 7 (early WHF) with WHF occurring at any time during admission. The primary endpoint was cardiovascular (CV) death and HF rehospitalizations through day 60.
RESULTS: We included 387 consecutive patients. Median length of stay was 11days (interquartile range 8-18days). Forty-five patients (11.6%) had WHF, HF rehospitalization, or death through day 7 whereas 90 (23.3%) had WHF or died at any time during initial hospitalization. Patients with WHF occurring any time during admission were more symptomatic, had lower systolic blood pressure, worse renal function, and higher troponins at baseline. Both early WHF and WHF at any time during hospitalization were associated with a longer length of stay and higher CV death and HF rehospitalization rates at day 60, but only WHF at any time was associated with all-cause death at day 180 (adjusted HR 2.42 95% CI 1.30, 4.52; p=0.0055) and with all-cause death any time during the follow-up period (adjusted HR 1.60 95% CI 1.02, 2.53; p=0.0425).
CONCLUSIONS: Our study confirms the prognostic significance of WHF and shows the independent prognostic value of WHF also for long-term mortality when assessed throughout hospitalization.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acute heart failure; In-hospital worsening heart failure; Outcomes; Prognosis

Mesh:

Year:  2016        PMID: 27756041     DOI: 10.1016/j.ijcard.2016.10.002

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  From Skepticism to Hope: The Evolving Concept of the Initiation and Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients.

Authors:  Theocharis Koufakis; Omar G Mustafa; Ramzi A Ajjan; Xavier Garcia-Moll; Pantelis Zebekakis; George Dimitriadis; Kalliopi Kotsa
Journal:  Drugs       Date:  2022-06-09       Impact factor: 11.431

2.  Cardiac cycle time-corrected electromechanical activation time greater than 15% is an independent risk factor for major adverse cardiovascular events in chronic heart failure outpatients.

Authors:  Jing Zhang; Wenxian Liu
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

3.  Patterns of dyspnoea onset in patients with acute heart failure: clinical and prognostic implications.

Authors:  Justyna Maria Sokolska; Mateusz Sokolski; Robert Zymliński; Jan Biegus; Paweł Siwołowski; Sylwia Nawrocka-Millward; Ewa Anita Jankowska; John Todd; Waldemar Banasiak; Piotr Ponikowski
Journal:  ESC Heart Fail       Date:  2018-11-13

4.  Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients.

Authors:  Jing Zhang; Wen-Xian Liu; Shu-Zheng Lyu
Journal:  Cardiovasc Ther       Date:  2020-01-02       Impact factor: 3.023

5.  Precipitating Factors Leading to Hospitalization and Mortality in Heart Failure Patients: Findings from Gulf CARE.

Authors:  Abdulla Shehab; Kadhim Sulaiman; Feras Barder; Haitham Amin; Amar M Salam
Journal:  Heart Views       Date:  2022-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.